Malcolm D. Mason
Active 1989–2024
- Also published as
- Malcolm D Mason
- 119
- Papers
- 43,162
- Citations
- 93
- h-index
- 119
- i10-index
Citations
Citation sources
Countries
Institutions
Fields
- Medicine61.7%
- Biochemistry, Genetics and Molecular Biology30.4%
- Immunology and Microbiology3%
- Engineering0.8%
- Health Professions0.6%
- Computer Science0.6%
- Other2.9%
Topics
- Prostate Cancer Treatment and Research13.4%
- Prostate Cancer Diagnosis and Treatment12.9%
- Extracellular vesicles in disease7.5%
- MicroRNA in disease regulation4.3%
- Radiopharmaceutical Chemistry and Applications2.5%
- Advanced Radiotherapy Techniques2.1%
- Other57.3%
Coauthors
- Silke Gillessen23
- David P. Dearnaley21
- Noel W. Clarke21
- Maria De Santis19
- Erik Briers18
- Nicholas D. James18
- Nicolas Mottet18
- Thomas Wiegel18
- Aled Clayton17
- Ann Henry17
- Olivier Rouvière17
- Matthew R. Sydes16
- Philip Cornford16
- Theodorus van der Kwast16
- Gerhardt Attard15
- Henk G. van der Poel15
- Roderick C.N. van den Bergh15
- Thomas Lam15
- Thomas Van den Broeck15
- Howard Kynaston14
- Ivo G. Schoots14
- Mahesh Parmar14
- A.W.S. Ritchie13
- Alison Birtle13
All papers
- EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer—2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
Authors: Nicolas Mottet, Roderick C.N. van den Bergh, Erik Briers, Thomas Van den Broeck, Marcus Cumberbatch, Maria De Santis, Stefano Fanti, Nicola Fossati, Giorgio Gandaglia, Silke Gillessen, Nikos Grivas, Jeremy Grummet, Ann Henry, Theodorus van der Kwast, Thomas Lam, Michael Lardas, Matthew Liew, Malcolm D. Mason, Lisa Moris, Daniela E. Oprea‐Lager, Henk G. van der Poel, Olivier Rouvière, Ivo G. Schoots, Derya Tilki, Thomas Wiegel, Peter-Paul Willemse, Philip Cornford - European Urology 2020 cited by 2,814
- Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer
Authors: Freddie C. Hamdy, Jenny Donovan, J. Athene Lane, Chris Metcalfe, Michael Davis, Emma L. Turner, Richard M. Martin, Grace Young, Eleanor Walsh, Richard J. Bryant, Prasad Bollina, Andrew Doble, Alan Doherty, David Gillatt, Vincent J. Gnanapragasam, Owen Hughes, Roger Kockelbergh, Howard Kynaston, Alan Paul, Edgar Páez, Philip Powell, Derek J. Rosario, Edward Rowe, Malcolm D. Mason, James W.F. Catto, T. J. Peters, Jon Oxley, Naomi Williams, John Staffurth, David E. Neal - New England Journal of Medicine 2023 cited by 751
- Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy
Authors: Nicholas D. James, Johann S. de Bono, Melissa Spears, Noel W. Clarke, Malcolm D. Mason, David P. Dearnaley, A.W.S. Ritchie, Claire Amos, Clare Gilson, Robert J. Jones, David Matheson, Robin Millman, Gerhardt Attard, Simon Chowdhury, William Cross, Silke Gillessen, Christopher Parker, John M. Russell, Dominik Berthold, Chris Brawley, F. Adab, San Aung, Alison Birtle, Jo Bowen, Susannah Brock, Prabir Chakraborti, Catherine Ferguson, Joanna Gale, Emma Gray, Mohan Hingorani, Peter Hoskin, J.F. Lester, Zafar Malik, Fiona McKinna, Neil McPhail, Julian Money‐Kyrle, Joe M. O’Sullivan, Omi Parikh, Andrew Protheroe, Angus Robinson, Narayanan Srihari, Carys Thomas, John Wagstaff, James Wylie, Anjali Zarkar, Mahesh Parmar, Matthew R. Sydes - New England Journal of Medicine 2017 cited by 1,772
- EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II—2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer
Authors: Philip Cornford, Roderick C.N. van den Bergh, Erik Briers, Thomas Van den Broeck, Marcus Cumberbatch, Maria De Santis, Stefano Fanti, Nicola Fossati, Giorgio Gandaglia, Silke Gillessen, Nikolaos Grivas, Jeremy Grummet, Ann Henry, Theodorus van der Kwast, Thomas Lam, Michael Lardas, Matthew Liew, Malcolm D. Mason, Lisa Moris, Daniela E. Oprea‐Lager, Henk G. van der Poel, Olivier Rouvière, Ivo G. Schoots, Derya Tilki, Thomas Wiegel, Peter-Paul Willemse, Nicolas Mottet - European Urology 2020 cited by 1,126
- Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
Authors: Nicholas D. James, Matthew R. Sydes, Noel W. Clarke, Malcolm D. Mason, David P. Dearnaley, Melissa Spears, A.W.S. Ritchie, Christopher Parker, John M. Russell, Gerhardt Attard, Johann S. de Bono, William Cross, Robert J. Jones, George N. Thalmann, Claire Amos, David Matheson, Robin Millman, Mymoona Alzouebi, S. Beesley, Alison Birtle, Susannah Brock, Richard Cathomas, Prabir Chakraborti, Simon Chowdhury, Audrey Cook, Tony Elliott, Joanna Gale, Stephanie Gibbs, John D. Graham, John Hetherington, Robert Hughes, Robert Laing, Fiona McKinna, Duncan B. McLaren, Joe M. O’Sullivan, Omi Parikh, C. Peedell, Andrew Protheroe, Angus Robinson, Narayanan Srihari, Rajaguru Srinivasan, John Staffurth, Santhanam Sundar, Shaun Tolan, David Tsang, John Wagstaff, Mahesh Parmar - The Lancet 2015 cited by 1,968
- 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer
Authors: Freddie C. Hamdy, Jenny Donovan, J. Athene Lane, Malcolm D. Mason, Chris Metcalfe, Peter Holding, Michael Davis, T. J. Peters, Emma L. Turner, Richard M. Martin, Jon Oxley, Mary Robinson, John Staffurth, Eleanor Walsh, Prasad Bollina, James W.F. Catto, Andrew Doble, Alan Doherty, David Gillatt, Roger Kockelbergh, Howard Kynaston, Alan Paul, Philip Powell, Stephen M. Prescott, Derek J. Rosario, Edward Rowe, David E. Neal - New England Journal of Medicine 2016 cited by 2,650
- Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial
Authors: Christopher Parker, Nicholas D. James, Chris Brawley, Noel W. Clarke, Alex Hoyle, Adnan Ali, A.W.S. Ritchie, Gerhardt Attard, Simon Chowdhury, William Cross, David P. Dearnaley, Silke Gillessen, Clare Gilson, Robert J. Jones, Ruth E. Langley, Zafar Malik, Malcolm D. Mason, David Matheson, Robin Millman, John M. Russell, George N. Thalmann, Claire Amos, Roberto Alonzi, Amit Bahl, Alison Birtle, Omar Din, Hassan Douis, Chinnamani Eswar, Joanna Gale, Melissa Gannon, Sai Jonnada, Sara Khaksar, J.F. Lester, Joe M. O’Sullivan, Omi Parikh, Ian Pedley, Delia Pudney, D.J. Sheehan, Narayanan Srihari, Anna Tran, Mahesh Parmar, Matthew R. Sydes - The Lancet 2018 cited by 1,262
- EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
Authors: Nicolas Mottet, Joaquim Bellmunt, M. Bolla, Erik Briers, Marcus Cumberbatch, Maria De Santis, Nicola Fossati, Tobias Gross, Ann Henry, Steven Joniau, Thomas Lam, Malcolm D. Mason, В. Б. Матвеев, Paul C. Moldovan, Roderick C.N. van den Bergh, Thomas Van den Broeck, Henk G. van der Poel, Theodorus van der Kwast, Olivier Rouvière, Ivo G. Schoots, Thomas Wiegel, Philip Cornford - European Urology 2016 cited by 3,260
- Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review
Authors: Thomas Van den Broeck, Roderick C.N. van den Bergh, Nicolas Arfi, Tobias Gross, Lisa Moris, Erik Briers, Marcus Cumberbatch, Maria De Santis, Derya Tilki, Stefano Fanti, Nicola Fossati, Silke Gillessen, Jeremy Grummet, Ann Henry, Michael Lardas, Matthew Liew, Olivier Rouvière, Jakub Pecanka, Malcolm D. Mason, Ivo G. Schoots, Theodorus van der Kwast, Henk G. van der Poel, Thomas Wiegel, Peter-Paul M. Willemse, Yuhong Yuan, Thomas Lam, Philip Cornford, Nicolas Mottet - European Urology 2018 cited by 517
- Cancer Exosomes Trigger Fibroblast to Myofibroblast Differentiation
Authors: Jason Webber, Robert Steadman, Malcolm D. Mason, Zsuzsanna Tabi, Aled Clayton - Cancer Research 2010 cited by 834
- Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol
Authors: Gerhardt Attard, Laura Murphy, Noel W Clarke, William Cross, Robert J Jones, Christopher C Parker, Silke Gillessen, Adrian Cook, Chris Brawley, Claire L Amos, Nafisah Atako, Cheryl Pugh, Michelle Buckner, Simon Chowdhury, Zafar Malik, J Martin Russell, Clare Gilson, Hannah Rush, Jo Bowen, Anna Lydon, Ian Pedley, Joe M O'Sullivan, Alison Birtle, Joanna Gale, Narayanan Srihari, Carys Thomas, Jacob Tanguay, John Wagstaff, Prantik Das, Emma Gray, Mymoona Alzoueb, Omi Parikh, Angus Robinson, Isabel Syndikus, James Wylie, Anjali Zarkar, George Thalmann, Johann S de Bono, David P Dearnaley, Malcolm D Mason, Duncan Gilbert, Ruth E Langley, Robin Millman, David Matheson, Matthew R Sydes, Louise C Brown, Mahesh K B Parmar, Nicholas D James, Elin Jones, Katherine Hyde, Hilary Glen, Sarah Needleman, Ursula McGovern, Denise Sheehan, Sangeeta Paisey, Richard Shaffer, Mark Beresford, Zafar Malik, Anjali Zarkar, Emilio Porfiri, David Fackrell, Ling Lee, Thiagarajan Sreenivasan, Sue Brock, Simon Brown, Amit Bahl, Mike Smith-Howell, Cathryn Woodward, Mau-Don Phan, Danish Mazhar, Krishna Narahari, Jacob Tanguay, Fiona Douglas, Anil Kumar, Abdel Hamid, Azman Ibrahim, Dakshinamoorthy Muthukumar, Matthew Simms, Jane Worlding, Anna Tran, Mohammed Kagzi, Prantik Das, Carmel Pezaro, Virgil Sivoglo, Benjamin Masters, Pek Keng-Koh, Caroline Manetta, Duncan McLaren, Nishi Gupta, Denise Sheehan, Stergios Boussios, Henry Taylor, John Graham, Carla Perna, Lucinda Melcher, Warren Grant, Katherine Hyde, Ami Sabharwal, Uschi Hofmann, Robert Dealey and 73 more - The Lancet 2021 cited by 367
- EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer
Authors: Philip Cornford, Joaquim Bellmunt, M. Bolla, Erik Briers, Maria De Santis, Tobias Gross, Ann Henry, Steven Joniau, Thomas Lam, Malcolm D. Mason, Henk G. van der Poel, Theodorus van der Kwast, Olivier Rouvière, Thomas Wiegel, Nicolas Mottet - European Urology 2016 cited by 1,442
- Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer
Authors: Jenny Donovan, Freddie C. Hamdy, J. Athene Lane, Malcolm D. Mason, Chris Metcalfe, Eleanor Walsh, Jane Blazeby, T. J. Peters, Peter Holding, Susan Bonnington, Teresa Lennon, Lynne Bradshaw, Deborah Cooper, Phillipa Herbert, Joanne Howson, Amanda Jones, Norma Lyons, E. George Salter, Pauline Thompson, Sarah Tidball, Jan Blaikie, Catherine Gray, Prasad Bollina, James W.F. Catto, Andrew Doble, Alan Doherty, David Gillatt, Roger Kockelbergh, Howard Kynaston, Alan Paul, Philip A. Powell, Stephen M. Prescott, Derek J. Rosario, Edward Rowe, Michael J. Davis, Emma L. Turner, Richard M. Martin, David E. Neal - New England Journal of Medicine 2016 cited by 1,328
- Human Tumor-Derived Exosomes Down-Modulate NKG2D Expression
Authors: Aled Clayton, John P. Mitchell, Jacquelyn Court, S.J. Linnane, Malcolm D. Mason, Zsuzsanna Tabi - The Journal of Immunology 2008 cited by 561
- The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review
Authors: Nicola Fossati, Peter-Paul Willemse, Thomas Van den Broeck, Roderick C.N. van den Bergh, Cathy Yuhong Yuan, Erik Briers, Joaquim Bellmunt, M. Bolla, Philip Cornford, Maria De Santis, Ekelechi MacPepple, Ann Henry, Malcolm D. Mason, В. Б. Матвеев, Henk G. van der Poel, Theodorus van der Kwast, Olivier Rouvière, Ivo G. Schoots, Thomas Wiegel, Thomas Lam, Nicolas Mottet, Steven Joniau - European Urology 2017 cited by 533
- Cancer Exosomes Express CD39 and CD73, Which Suppress T Cells through Adenosine Production
Authors: Aled Clayton, Saly Al‐Taei, Jason Webber, Malcolm D. Mason, Zsuzsanna Tabi - The Journal of Immunology 2011 cited by 537
- Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial
Authors: N.W. Clarke, Amin Ali, Fiona C. Ingleby, Alex Hoyle, Claire Amos, Gerhardt Attard, Chris Brawley, J. Calvert, S. Chowdhury, Audrey Cook, William Cross, David P. Dearnaley, Hassan Douis, Duncan C. Gilbert, Silke Gillessen, Robert J. Jones, Ruth E. Langley, Archie Macnair, Zafar Malik, Malcolm D. Mason, David Matheson, R. Millman, Chris Parker, A.W.S. Ritchie, Hannah Rush, John M. Russell, Janet E. Brown, S. Beesley, Alison Birtle, Lisa Capaldi, Joanna Gale, Stephanie Gibbs, Anna Lydon, Ashok Nikapota, Aurelius Omlin, Joe M. O’Sullivan, Omi Parikh, Andrew Protheroe, Sarah Rudman, Narayanan Srihari, Matthew Simms, Jacob Tanguay, Shaun Tolan, John Wagstaff, Jan Wallace, J. Wylie, Anjali Zarkar, Matthew R. Sydes, Mahesh Parmar, Nicholas D. James - Annals of Oncology 2019 cited by 398
- Antigen‐presenting cell exosomes are protected from complement‐mediated lysis by expression of CD55 and CD59
Authors: Aled Clayton, Claire L. Harris, Jacquelyn Court, Malcolm D. Mason, B. Paul Morgan - European Journal of Immunology 2003 cited by 337
- Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol
Authors: Gerhardt Attard, Laura Murphy, Noel W. Clarke, Ashwin Sachdeva, Craig Jones, Alex Hoyle, William Cross, Robert J. Jones, Christopher Parker, Silke Gillessen, Adrian Cook, Chris Brawley, Clare Gilson, Hannah Rush, Hoda Abdel-Aty, Claire Amos, Claire Murphy, Simon Chowdhury, Zafar Malik, John M. Russell, Nazia Parkar, Cheryl Pugh, Carlos Díaz-Montaña, Carmel Pezaro, Warren Grant, Helen Saxby, Ian Pedley, Joe M. O’Sullivan, Alison Birtle, Joanna Gale, Narayanan Srihari, Carys Thomas, Jacob Tanguay, John Wagstaff, Prantik Das, Emma Gray, Mymoona Alzouebi, Omi Parikh, Angus Robinson, Amir Montazeri, James Wylie, Anjali Zarkar, Richard Cathomas, Michael D. Brown, Yatin Jain, David P. Dearnaley, Malcolm D. Mason, Duncan C. Gilbert, Ruth E. Langley, Robin Millman, David Matheson, Matthew R. Sydes, Louise Brown, Mahesh Parmar, Nicholas D. James, Elin Jones, Katherine Hyde, Hilary Glen, Sarah Needleman, Ursula McGovern, Denise Sheehan, Sangeeta Paisey, Richard Shaffer, Mark Beresford, Zafar Malik, Anjali Zarkar, Emilio Porfiri, David Fackrell, Ling Lee, Thiagarajan Sreenivasan, Sue Brock, Simon Brown, Amit Bahl, Mike Smith-Howell, Cathryn Woodward, Mau-Don Phan, Danish Mazhar, Krishna Narahari, Jacob Tanguay, Fiona Douglas, Anil Kumar, Abdel Hamid, Azman Ibrahim, D. Muthukumar, Matthew Simms, Jane Worlding, Anna Tran, M. Kagzi, Prantik Das, Carmel Pezaro, Virgil Sivoglo, Benjamin Masters, Pek Keng-Koh, Caroline Manetta, Duncan B. McLaren, Nishi Gupta, Denise Sheehan, Stergios Boussios, Henry M. Taylor, John D. Graham and 80 more - The Lancet Oncology 2023 cited by 102
- Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry
Authors: Aled Clayton, Jacquelyn Court, H. Navabi, Malcolm Adams, Malcolm D. Mason, Jan A. Hobot, Geoff R. Newman, Bharat Jasani - Journal of Immunological Methods 2001 cited by 553
- Differentiation of tumour-promoting stromal myofibroblasts by cancer exosomes
Authors: Jason Webber, Lisa K. Spary, Andrew J. Sanders, R Chowdhury, Wen G. Jiang, Robert Steadman, Jennifer M. Wymant, Arwyn T. Jones, Howard Kynaston, Malcolm D. Mason, Zsuzsanna Tabi, Aled Clayton - Oncogene 2014 cited by 424
- Biochemical Recurrence in Prostate Cancer: The European Association of Urology Prostate Cancer Guidelines Panel Recommendations
Authors: Thomas Van den Broeck, Roderick C.N. van den Bergh, Erik Briers, Philip Cornford, Marcus Cumberbatch, Derya Tilki, Maria De Santis, Stefano Fanti, Nicola Fossati, Silke Gillessen, Jeremy Grummet, Ann Henry, Michael Lardas, Matthew Liew, Malcolm D. Mason, Lisa Moris, Ivo G. Schoots, Theodorus van der Kwast, Henk G. van der Poel, Thomas Wiegel, Peter-Paul M. Willemse, Olivier Rouvière, Thomas Lam, Nicolas Mottet - European Urology Focus 2019 cited by 242
- Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial
Authors: Chris Parker, Nicholas D. James, Chris Brawley, Noel W. Clarke, Adnan Ali, Claire Amos, Gerhardt Attard, Simon Chowdhury, Adrian Cook, William Cross, David P. Dearnaley, Hassan Douis, Duncan C. Gilbert, Clare Gilson, Silke Gillessen, Alex Hoyle, Robert J. Jones, Ruth E. Langley, Zafar Malik, Malcolm D. Mason, David Matheson, Robin Millman, Mary Rauchenberger, Hannah Rush, Martin Russell, Hannah Sweeney, Amit Bahl, Alison Birtle, Lisa Capaldi, Omar Din, Daniel Ford, Joanna Gale, Ann Henry, Peter Hoskin, M. Kagzi, Anna Lydon, Joe M. O’Sullivan, Sangeeta Paisey, Omi Parikh, Delia Pudney, Vijay Ramani, Peter Robson, Narayanan Srihari, Jacob Tanguay, Mahesh Parmar, Matthew R. Sydes, for the STAMPEDE Trial Collaborative Group - PLoS Medicine 2022 cited by 121
- Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5‐year follow‐up results from the STAMPEDE randomised trial (NCT00268476)
Authors: Nicholas D. James, Noel W. Clarke, Adrian Cook, Adnan Ali, Alex Hoyle, Gerhardt Attard, Chris Brawley, Simon Chowdhury, William Cross, David P. Dearnaley, Johann S. de Bono, Carlos Díaz-Montaña, Duncan C. Gilbert, Silke Gillessen, Clare Gilson, Robert J. Jones, Ruth E. Langley, Zafar Malik, David Matheson, Robin Millman, Chris Parker, Cheryl Pugh, Hannah Rush, John M. Russell, Dominik Berthold, Michelle Buckner, Malcolm D. Mason, A.W.S. Ritchie, Alison Birtle, Susannah Brock, Prantik Das, Dan Ford, Joanna Gale, Warren Grant, Emma Gray, Peter Hoskin, Mohammad Muneeb Khan, Caroline Manetta, Neil McPhail, Joe M. O’Sullivan, Omi Parikh, Carla Perna, Carmel Pezaro, Andrew Protheroe, Angus Robinson, Sarah Maria Rudman, D.J. Sheehan, Narayanan Srihari, Isabel Syndikus, Jacob Tanguay, Carys Thomas, Salil Vengalil, John Wagstaff, James Wylie, Mahesh Parmar, Matthew R. Sydes, for the STAMPEDE Trials Collaborative Group - International Journal of Cancer 2022 cited by 77
